Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test.
Qi HuangZheng LiuYipei YuZhiwei RongPeiyu WangShaodong WangHao WuXiang YanWilliam Chi Shing ChoTeng MuJilun LiJia ZhaoMan-Tang QiuYan HouXiangnan LiPublished in: British journal of cancer (2024)
Since CT has inherent weakness in hollow organ assessment and no other ideal biomarker has been found, our study provided a noninvasive, feasible, and inexpensive tool that could precisely predict ESCC patients' response to neoadjuvant chemo-immunotherapy combination using breath test based on HPPI-TOFMS.
Keyphrases
- locally advanced
- rectal cancer
- end stage renal disease
- photodynamic therapy
- lymph node
- ejection fraction
- newly diagnosed
- chronic kidney disease
- computed tomography
- prognostic factors
- cancer therapy
- peritoneal dialysis
- magnetic resonance imaging
- radiation therapy
- combination therapy
- image quality
- patient reported outcomes
- dual energy
- molecularly imprinted
- high resolution
- patient reported
- simultaneous determination